NO20021900L - FremgangsmÕte for analyse av forbindelsers hormonvirkning - Google Patents

FremgangsmÕte for analyse av forbindelsers hormonvirkning

Info

Publication number
NO20021900L
NO20021900L NO20021900A NO20021900A NO20021900L NO 20021900 L NO20021900 L NO 20021900L NO 20021900 A NO20021900 A NO 20021900A NO 20021900 A NO20021900 A NO 20021900A NO 20021900 L NO20021900 L NO 20021900L
Authority
NO
Norway
Prior art keywords
protein
dna
arap11
fragments
modulator
Prior art date
Application number
NO20021900A
Other languages
English (en)
Other versions
NO20021900D0 (no
Inventor
Maik Obendorf
Siegmund Wolf
Der Jens Schr
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10121710A external-priority patent/DE10121710A1/de
Priority claimed from DE2001161325 external-priority patent/DE10161325A1/de
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of NO20021900D0 publication Critical patent/NO20021900D0/no
Publication of NO20021900L publication Critical patent/NO20021900L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Saccharide Compounds (AREA)
NO20021900A 2001-05-04 2002-04-22 FremgangsmÕte for analyse av forbindelsers hormonvirkning NO20021900L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10121710A DE10121710A1 (de) 2001-05-04 2001-05-04 Verfahren zur Testung des hormonellen Effekts von Substanzen
DE2001161325 DE10161325A1 (de) 2001-12-13 2001-12-13 Verfahren zur Testung des hormonellen Effekts von Substanzen

Publications (2)

Publication Number Publication Date
NO20021900D0 NO20021900D0 (no) 2002-04-22
NO20021900L true NO20021900L (no) 2002-11-05

Family

ID=26009230

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021900A NO20021900L (no) 2001-05-04 2002-04-22 FremgangsmÕte for analyse av forbindelsers hormonvirkning

Country Status (10)

Country Link
US (1) US20030124508A1 (no)
EP (1) EP1255113B1 (no)
JP (1) JP4071033B2 (no)
AT (1) ATE267402T1 (no)
DE (1) DE50200452D1 (no)
DK (1) DK1255113T3 (no)
ES (1) ES2219601T3 (no)
NO (1) NO20021900L (no)
PT (1) PT1255113E (no)
TR (1) TR200402024T4 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10226674B4 (de) * 2002-06-12 2006-01-05 Schering Ag Verfahren zur Testung des hormonellen Effekts von Substanzen
DE10226675B4 (de) * 2002-06-12 2006-01-05 Schering Ag Verfahren zur Testung des hormonellen Effekts von Substanzen
EP2316328B1 (en) 2003-09-15 2012-05-09 Super Dimension Ltd. Wrap-around holding device for use with bronchoscopes
ATE556643T1 (de) 2003-09-15 2012-05-15 Super Dimension Ltd Umhüllungsvorrichtung zur fixierung von bronchoskopen
US8764725B2 (en) 2004-02-09 2014-07-01 Covidien Lp Directional anchoring mechanism, method and applications thereof
US7655700B2 (en) 2005-08-25 2010-02-02 Michigan State University Transgenic mouse model and methods for treatment of neuro muscular disease by interfering with androgen-androgen receptor interaction in skeletal muscles
US8905920B2 (en) 2007-09-27 2014-12-09 Covidien Lp Bronchoscope adapter and method
US8932207B2 (en) 2008-07-10 2015-01-13 Covidien Lp Integrated multi-functional endoscopic tool
WO2011159834A1 (en) 2010-06-15 2011-12-22 Superdimension, Ltd. Locatable expandable working channel and method
US10952593B2 (en) 2014-06-10 2021-03-23 Covidien Lp Bronchoscope adapter
US10426555B2 (en) 2015-06-03 2019-10-01 Covidien Lp Medical instrument with sensor for use in a system and method for electromagnetic navigation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506102A (en) * 1993-10-28 1996-04-09 Ligand Pharmaceuticals Incorporated Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription

Also Published As

Publication number Publication date
US20030124508A1 (en) 2003-07-03
DE50200452D1 (de) 2004-06-24
JP2003018996A (ja) 2003-01-21
PT1255113E (pt) 2004-10-29
TR200402024T4 (tr) 2004-09-21
EP1255113A1 (de) 2002-11-06
EP1255113B1 (de) 2004-05-19
ES2219601T3 (es) 2004-12-01
NO20021900D0 (no) 2002-04-22
DK1255113T3 (da) 2004-10-04
JP4071033B2 (ja) 2008-04-02
ATE267402T1 (de) 2004-06-15

Similar Documents

Publication Publication Date Title
NO20021900L (no) FremgangsmÕte for analyse av forbindelsers hormonvirkning
Solomon et al. Mitogen-activated protein kinase inhibits 1, 25-dihydroxyvitamin D 3–dependent signal transduction by phosphorylating human retinoid X receptor α
Boss et al. Uncoupling protein-3 expression in skeletal muscle and free fatty acids in obesity
NO984856D0 (no) Innretning for kvalitativ og/eller kvantitativ analyse av analytter, basert pÕ f°lsom magnetisk deteksjon
ATE378418T1 (de) Extrazelluläres, neues rage-bindendes protein (en-rage) und dessen verwendungen
IS4971A (is) Aðferð til að greina ástand lífveru með mælingu ápeptíðum
DE60106228D1 (de) Elektrochemischer biosensor-teststreifen mit erkennungselektrode und auslesemessgerät, das diesen teststreifen verwendet
Casbarra et al. Conformational analysis of HAMLET, the folding variant of human α‐lactalbumin associated with apoptosis
NO20045176L (no) Fremgangsmate og anvendelse ved drift av et maleapparat som har flere diagnosefunksjoner, og maleapparat, saerlig magnetisk/induktivt volumstrommaleapparat
Kito et al. Downregulation of the Ca2+-activated K+ channel KCa3. 1 in mouse preosteoblast cells treated with vitamin D receptor agonist
Mullen et al. Red blood cells from COVID-19 patients suffer from increased oxidative stress and may have increased lactate influx
EP1196776A1 (en) Fluorescent intensity method for assaying binding between proteins or peptides
ATE196013T1 (de) Nachweisung von elektromagnetischen feldern
Steinkellner et al. A high throughput electrochemiluminescence assay for the quantification of frataxin protein levels
Bianchi et al. The tumor suppressor p16Ink4a regulates T lymphocyte survival
Parwanto et al. The effect of sex hormone binding globulin (SHBG) protein polymorphism on the levels of SHBG, testosterone, and insulin in healthy Indonesian men
DE69829587D1 (de) Nukleinsäuremoleküle, die mit dem schwachen rhesus-d phänotyp korrelieren
ATE294395T1 (de) Verfahren zur testung des hormonellen effekts von substanzen
Ozkan et al. Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels
Wang et al. Common genetic mutations in the start codon of the SDH subunit D gene among Chinese families with familial head and neck paragangliomas
Dumortier et al. The Mechanism of Tubulin‐Colchicine Recognition: A Kinetic Study of the Binding of a Bicyclic Colchicine Analogue with a Minor Modification of the A Ring
EP1376136A3 (de) Verfahren zur Testung des hormonellen Effekts von Substanzen
Ebrinç Psychiatric rating scales and their use in clinical studies
Ghahremani et al. Epigenetic alterations associated with premature ovarian failure
DK1455190T3 (da) Fremgangsmåde til bestemmelse af den hormonelle virkning af stoffer ved hjælp af vekselvirkningen mellem androgenreceptoren og Ewings sarkom protein

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application